Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines ...

Late-Breaking scientific poster at the American Thoracic Society Advances in Pulmonary Vascular Disease sessions will present AV-001 activity in SARS-CoV-2 Infection/COVID-19 Vasomune Therapeutics ...

angiotensin II type 2 receptor agonists (ATRAGs), today announced that the Company will present multiple oral presentations and posters at the 2025 American Thoracic Society (ATS) International ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) ...